Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
KLASIFIKASI CEDERA
KEPALA
Cedera kepala ringan
15
Cedera kepala sedang
12
Cedera kepala berat
Focal Injury
Diffuse Injury
Mechanism of Injury
Contact Forces
Inertial Forces
Inertial Forces
(Translational Acceleration) (Rotational Acceleration)
Traumatic
Brain Injury
Infection
Neurology
Impairment
Degenerative
Process
Cerebro Vascular
Injury
COMPLEX CASCADE
METABOLIC
PHYSIOLOGIC
FUNCTIONAL
ALTERATION
Operation
Radiotherap
y
Drugs
Antibiotic
SUCCESS
THERAPY
NUTRITION
NUTRITION
Cytokine Response
Counter Regularatory Hormone Released
HYPERMETABOLISM
HYPERCATABOLISM
NITROGEN WASTING
VISCERAL PROTEIN
TRAUMATIC
BRAIN
INJURY
NUTRITION
ASSESSMENT
NUTRITION ASSESSMENT
Energy Requirement
Non-protein calorie requirements:
Protein requirement:
1.5 2 g of protein/kg BW/day hypermetabolic
and hypercatabolic
Micronutrients requirements:
Zinc, Iron, and Copper play different roles in
immune functions & important in the recoevery of
HI patients
NUTRITION ASSESSMENT
Functional GI Tract
Yes
No
ENTERAL NUTRITION
LONG TERM
Gastrostomy
Jejunostomy
SHORT TERM
Nasogastric
Nasoduodenal
Nasojejunal
GI FUNCTION
NORMAL
COMPROMISED
STANDARD
NUTRIENTS
SPECIALITY
FORMULA
Nutrient
Tolerance
Adequate
Inadequate
Progres to
PN
Oral
Feedings Supplementation
Progres to
Enteral Feedings
PARENTERAL NUTRITION
SHORT TERM
PERIPHERAL
PN
GI FUNCTION
RETURNS
Adequate
NO
YES
Progres to More
Complex Diet
Guidelines for the Use of Parenteral and
And
Enteral Nutrition in Adults and Pediatric
Oral Feeding as
Patients. ASPEN Board of Directors & Clinical
Tolerated
Guidelines Task Force, JPEN, 26 (1) Suppl, 2002.
Enteral Nutrition
Enteral Formulas
Polymeric Formula
Commerical preparations
Hospital (blenderized) preparations
Oligomeric Formula
Disease specific Formula:
Immunonutrition
Modular Formula
Arginine
Ornithine
Glutamine
Proline
Immuno-enhancing
arginase
Polyamine
Wound healing
Protein
Energy metabolism
Omega-3
PRO INFLAMMATION
ANTI INFLAMMATION
Immune-enhanced Diet
An Immune-enhancing nutrient is a
substance that provides identifiable
salutary effects upon the immune system.
L-arginine
L-glutamine
Nucleotides
LC-PUFA: EPA, DHA & AA
Glutamine
Neomune
Group: Immunonutrition
48 gram/sachet
Composition per sachet
CHO: 25.01 g
Fructose + Maltodextrin
F: 5.79 g
MCT + Fish Oil + Corn
Oil
P: 12.5 g
Casein + Arginin +
Glutamin
Fibre (+)
Free lactose
1 kcal/ml
Total Calorie: 200 Kcal/sachet
Neomune
% calorie
% W/W
g/1000 kcal
Protein
Kasein 70%
Arginine 20%
Glutamine 10%
25
26.1
62.5
Fat
MCT 50%
Corn Oil 30%
Fish Oil 20%
25
Carbohydrate
Dextrin 90%
Fructose 10%
50
Composition
12.5
6.25
12.1
28
5.55
52.1
125
10
Vitamin: Vit A, -caroten; Vit D, E, B1, B2, B6, B12, C, Pantotenat acid, Niasin, Folic
acid, Biotin, Choline, Vit K, Taurine, L-carnitine.
Mineral: Ca, P, I, Fe, Mg, Cu, Zn, Mn, Cl, K, Na
Neomune
Recommended Administration
To be given 4 to 5 sachet per day for 7 14
days continuously.
ICU days
5
4
3
2
1
0
Traumacal Neo-mune
Traumacal Neo-mune
Parenteral Nutrition
Carbohydrate solutions
PPN: Trifluid , KaEn MG3 , Otsu-D5, Otsu-D10
TPN: Triparen 1 & 2
Lipid solution:
Otsu-Lip
Vitamins:
OMVI
OSMOLARITY
Peripheral PN
Central PN
900
BCAA consists of 3
essential amino
acids:
L-isoleucine
L-leucine
L-valine
GLUCONEOGENESIS
saline
Gelatins
Hydroxyethyl starch
Hypertonic saline
Hypotonic fluid
Mannitol
Osmolality mosm/l
2400
1100
308
310
285
250-260
252
Osmolarity
(mOsm/L)
Oncotic
Pressure
273
(mmHg)
0
525
0.9% Saline
308
D5-0.45% Saline
406
0.45% Saline
154
20% Mannitol
1098
310
3116
Dextran 40(10%)(MW:40.000)
300
16926
Dextran 70(6%)(MW:70.000)
300
1926
290
19
Plasma
290
21
Hypertonic Saline
in ICP in resistant intracranial
hypertension brain
C.O
Peripheral & cerebrovascular resistance
Economical benefit
Plasma osmolarity
Sodium & Chloride
Potassium
- Cerebral dehydration Possible due to
rapid
change in serum Na+
- Close monitoring Na+ levels & osm.
Effective
Hypotonic Fluids
Traditionally
preoperative : to
prevent hypoglycemia
Prevent protein catabolism
Hyperglycemia in neurosurgery :
worse outcome in ischemic &
traumatic brain injury
Dextrose rapidly metabolized free
water brain water
Mannitol
PROLONGED ACTION :
Exacerbate cerebral edema
ICP
Breakdown BBB
BEST : - in acute fase to ICP
Cave : - ATN : Shock sepsis, nefrotoxic
drugs
- Hypervolumic condition
Dextrose Solutions,
Hyperglycemia
Clinical implication
Hyperglycemia should be avoided in patients
who are at risk for an ischemic event.
Dextrose solutions should not be infused in
patients undergoing neurosurgical
procedures, unless they are needed for the
treatment or prevention of hypoglycemia.
Intraoperative Fluids,
Crystalloids
(mOsm/L)
273
273
Ringers Solution
310
0.9% Saline
308
0.45% Saline
154
20% Mannitol
1098
290-295
Intraoperative Fluids,
Colloids
F l u i d
Osmolarity
(mOsm/L)
Oncotic
Pressure
310
(mmHg)
3116
Dextran 40(10%)(MW:40.000)
300
16926
Dextran 70(6%)(MW:70.000)
300
1926
290
19
Polygeline (Haemaccel)
310
21
Plasma
290
21
Diabetes Insipidus
Pointers
THANK YOU